Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1453, Issue 1, 1999, Pages 63-73

  Gupta, Kalpna ^a   Gupta, Pankaj ^a,b   Solovey, Anna ^a   Hebbel, Robert P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Adhesion; Endothelium; Heparan sulfate; Heparin; Sickle cell disease; Thrombospondin

Indexed keywords

CELL SURFACE RECEPTOR; HEPARAN SULFATE; HEPARIN; THROMBOSPONDIN;

ARTICLE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SICKLE CELL; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; ANTIGENS, CD36; CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; RECEPTORS, VITRONECTIN; THROMBOSPONDINS;

EID: 0032898355     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00085-4     Document Type: Article

References (49)

1. R.P. Hebbel, M.O.A.B. Boogaerts, J.W. Eaton, M.H. Steinberg, Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity, N. Engl. J. Med. 302 (1980) 992-995.
2. T.M. Wick, J.R. Eckman, Molecular basis of sickle cell-endothelial cell interactions, Curr. Opin. Hematol. 3 (1996) 118-124.
3. K. Sugihara, T. Sugihara, N. Mohandas, R.P. Hebbel, Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells, Blood 80 (1992) 2634-2642.
4. G.A. Barabino, R.J. Wise, V.A. Woodbury, B. Zhang, K.A. Bridges, R.P. Hebbel, J. Lawler, B.M. Ewenstein, Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions, Blood 89 (1997) 2560-2567.
5. H.A. Brittain, J.R. Eckman, R.A. Swerlick, R.J. Howard, T.M. Wick, Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion, Blood 81 (1993) 2137-2143.
6. P.V. Browne, D. Mosher, M.H. Steinberg, R.P. Hebbel, Disturbance of plasma and platelet thrombospondin levels in sickle cell anemia, Am. J. Hematol. 51 (1996) 296-301.
7. J.C. Adams, R.P. Tucker, J. Lawler (Eds.), The Thrombospondin Gene Family, Springer, New York, 1995, pp. 105-157.
8. P. Bornstein, Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1, J. Cell Biol. 130 (1995) 503-506.
9. W.A. Frazier, Thrombospondins, Curr. Opin. Cell Biol. 3 (1991) 792-799.
10. D.F. Mosher, Physiology of thrombospondin, Annu. Rev. Med. 41 (1990) 85-97.
11. G. Taraboletti, D. Roberts, L.A. Liotta, R. Giavazzi, Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor, J. Cell Biol. 111 (1990) 765-772.
12. N. Guo, H.C. Krutzsch, J.K. Inman, D.D. Roberts, Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells, Cancer Res. 57 (1997) 1735-1742.
13. N. Bouck, V. Stellmach, S. Hsu, How tumors become angiogenic, Adv. Cancer Res. 69 (1996) 135-174.
14. S.S. Tolsma, O.V. Volpert, D.J. Good, W.A. Frazier, P.J. Polverini, N. Bouck N, Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity, J. Cell Biol. 122 (1993) 497-511.
15. S.S. Tolsma, M.S. Stack, N. Bouck, Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1, Microvasc. Res. 54 (1997) 13-26.
16. J.E. Murphy-Ullrich, D.F. Mosher, Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation, J. Cell Biol. 105 (1987) 1603-1611.
17. D.D. Roberts, Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells, Cancer Res. 48 (1988) 6785-6793.
18. P. Clezardin, J. Lawler, J. Amiral, G. Quentin, P. Delmas, Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1, Biochem. J. 321 (1997) 819-827.
19. A.S. Asch, S. Silbiger, E. Heimer, R.L. Nachman, Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding, Biochem. Biophys. Res. Commun. 182 (1992) 1208-1217.
20. J. Lawler, R. Weinstein, R.O. Hynes, Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors, J. Cell Biol. 107 (1988) 2351-2361.
21. 1 integrins, J. Immunol. 151 (1993) 149-158.
22. J. Lawler, The interaction of thrombospondin with integrins, in: J. Lahav (Ed.), Thrombospondin, CRC Press, Boca Raton, FL, 1993, pp. 275-282.
23. A.-G. Gao, F.P. Lindberg, M.B. Finn, S.D. Blystone, E.J. Brown, W.A. Frazier, Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin, J. Biol. Chem. 271 (1996) 21-24.
24. P. Schön, P. Vischer, W. Völker, A. Schmidt, V. Faber, Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells, Eur. J. Cell Biol. 59 (1992) 329-339.
25. Z.-S. Chen, J. Pohl, T.J. Lawley, R.A. Swerlick, Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism, J. Invest. Dermatol. 106 (1996) 215-220.
26. F. Re, A. Zanetti, M. Sironi, N. Polentarutti, L. Lanfrancone, E. Dejana, F. Colotta, Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells, J. Cell Biol. 127 (1994) 537-546.
27. Y. Watanabe, H.F. Dvorak, Vascular permeability factor/ vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation, Exp. Cell Res. 233 (1997) 340-349.
28. C.C. Joneckis, D.D. Shock, M.L. Cunningham, E.P. Orringer, L.V. Parise, Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions, Blood 87 (1996) 4862-4870.
29. K. Gupta, S. Ramakrishnan, P.V. Browne, A. Solovey, R.P. Hebbel, A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor, Exp. Cell Res. 230 (1997) 244-251.
30. J.E. Enenstein, K. Gupta, G.M. Vercellotti, R.P. Hebbel, Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36, Exp. Cell Res. 238 (1998) 465-471.
31. T. Bacon-Baguley, B.J. Kudryk, D.A. Walz, Thrombospondin interaction with fibrinogen: evidence for binding to the Aα- and Bβ- chains of fibrinogen, J. Biol. Chem. 262 (1987) 1927-1930.
32. M. Jaseja, R.N. Rej, F. Sauriol, A.S. Perlin, Novel regio-and stereoselective modifications of heparin in alkaline solution: nuclear magnetic resonance spectroscopic evidence, Can. J. Chem. 67 (1989) 1449-1456.
33. 3, J. Biol. Chem. 272 (1997) 14740-14746.
34. D.W. Dawson, S.F.A. Pearce, R. Zhong, R.L. Silverstein, W.A. Frazier, N.P. Bouck, CD36 mediates the in vitro inhibitory effects of thrombospondin-2 on endothelial cells, J. Cell Biol. 138 (1997) 707-717.
35. W.A. Frazier, Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells, J. Cell Biol. 105 (1987) 625-799.
36. R.A. Swerlick, K.H. Lee, T.M. Wick, T.J. Lawley, Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro, J. Immunol. 148 (1992) 78-83.
37. C.A. Hillery, M.C. Du, R.R. Montgomery, J.P. Scott, Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin, Blood 87 (1996) 4879-4886.
38. N. Mohandas, E. Evans, Characterization of cellular determinants and plasma factors responsible for increased adherence of sickle cells to vascular endothelium, in: R.L. Nagel (Ed.), Pathophysiological Aspects of Sickle Cell Vaso-occlusion, Liss, New York, 1987, pp. 181-189.
39. J.D. San Antonio, J. Slover, J. Lawler, M.J. Karnovsky, A.D. Lander, Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin, Biochemistry 32 (1993) 4746-4755.
40. H.S. Slayter, G. Karp, B.E. Miller, R.D. Rosenberg, Binding properties of human thrombospondin: interaction with mucopolysaccharides, Semin. Thromb. Hemost. 13 (1987) 369-377.
41. F. Incardona, J. Lawler, D. Cataldo, A. Panet, Y. Legrand, J.M. Foidart, C. Legrand, Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells, J. Cell. Biochem. 62 (1996) 431-442.
42. S.T. Olson, I. Bjork, Role of protein conformational changes, surface approximation and protein cofactors in heparin-accelerated antithrombin-proteinase reactions, Adv. Exp. Med. Biol. 313 (1992) 155-165.
43. I. Vlodavsky, H.Q. Miao, B. Medalion, P. Danagher, D. Ron, Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor, Cancer Metastasis Rev. 15 (1996) 177-186.
44. M.G. Kinsella, T.N. Wight, Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration, J. Cell Biol. 102 (1986) 679-687.
45. M. Salmivirta, K. Lidholt, U. Lindahl, Heparan sulfate: a piece of information, FASEB J. 10 (1996) 1270-1279.
46. R. Wolff, E.F. Plow, M.H. Ginsberg, Interaction of thrombospondin with resting and stimulated human platelets, J. Biol. Chem. 261 (1986) 6840-6846.
47. G.P. Tuszynski, J. Karczewski, L. Smith, A. Murphy, V.L. Rothman, K.A. Knudsen, The GPIIb-IIIa-like complex may function as a human melanoma cell adhesion receptor for thrombospondin, Exp. Cell Res. 182 (1989) 473-481.
48. 3 function through integrin-associated protein, J. Cell Biol. 135 (1996) 533-544.
49. X. Sun, K. Skorstengaard, D.F. Mosher, Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin, J. Cell Biol. 118 (1992) 693-701.